LANGaware

LANGaware operates in digital health diagnostics, focusing on speech and language analysis for cognitive and mental health screening. Its stated use cases include identifying and monitoring conditions such as Mild Cognitive Impairment, Alzheimer’s disease, depression, and anxiety. The product range covers a screening platform, a provider-facing platform, a cloud API for third-party integration, and a clinical-trial support solution. This gives the company several potential routes into care delivery and research workflows rather than limiting its offering to a single standalone screening interface. Website information describes assessments based on short voice samples, support for English, Spanish, and Greek, and deployment through in-person, remote, and virtual workflows. LANGaware’s $2 million Seed round in October 2023 and partnerships with American TelePhysicians and Premier indicate activity in clinical and patient-engagement settings, while its funding stage and employee range suggest a smaller company than established healthcare technology providers.

LANGaware’s growth history shows an early, multi-stage financing path followed by a focus on product development and healthcare partnerships. The company was founded in 2019 and raised a $75,000 Pre-Seed round that December, led by Georgios Papadopoulos. It then raised Seed rounds of $572,825 in July 2020, led by Metavallon VC, and $1,694,050 in December 2021, also led by Metavallon VC. The October 4, 2023 Seed round added $2 million, led by Eleven Ventures, bringing recorded total funding to $4,341,875. That financing is a clear inflection point in the disclosed funding history; stated hiring priorities at the time included technology, product, and business development. Partnerships provide a second signal of the company’s expansion efforts: a collaboration with American TelePhysicians was announced in September 2023, and collaborations with Premier followed in January and July 2024, including a Patient Engagement Solutions agreement. The product portfolio also spans screening, API integration, provider workflows, and clinical-trial support.